Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Chemical Compound Review:

AC1LCVKO (1R,5S)-7,7- dimethylbicyclo[3.1.1]heptane

Synonyms: 6,6-dimethylbicyclo[3.1.1]heptane, bicyclo[3.1.1]heptane, 6,6-dimethyl-, (1R,5S)-6,6-dimethylbicyclo[3.1.1]heptane

Mitsumori, S. et al., Seno, K. et al., Tsuri, T. et al.

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

High impact information on bicyclo[3.1.1]heptane, 6,6-dimethyl-

Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane derivatives [1].
Thromboxane A2 receptor antagonists. II. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with the benzenesulfonylamino group [2].

Associations of bicyclo[3.1.1]heptane, 6,6-dimethyl- with other chemical compounds

Bicyclo[2.2.1]heptane and 6,6-dimethylbicyclo[3.1.1]heptane derivatives: orally active, potent, and selective prostaglandin D2 receptor antagonists [3].

References

Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane derivatives. Mitsumori, S., Tsuri, T., Honma, T., Hiramatsu, Y., Okada, T., Hashizume, H., Kida, S., Inagaki, M., Arimura, A., Yasui, K., Asanuma, F., Kishino, J., Ohtani, M. J. Med. Chem. (2003) [Pubmed]
Thromboxane A2 receptor antagonists. II. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with the benzenesulfonylamino group. Seno, K., Hagishita, S. Chem. Pharm. Bull. (1989) [Pubmed]
Bicyclo[2.2.1]heptane and 6,6-dimethylbicyclo[3.1.1]heptane derivatives: orally active, potent, and selective prostaglandin D2 receptor antagonists. Tsuri, T., Honma, T., Hiramatsu, Y., Okada, T., Hashizume, H., Mitsumori, S., Inagaki, M., Arimura, A., Yasui, K., Asanuma, F., Kishino, J., Ohtani, M. J. Med. Chem. (1997) [Pubmed]

Contributions to this collaborative article are from individual authors of WikiGenes or mined by the WikiGenes Data Mining Engine from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

Editor

Share